Interesting, I wonder if they plan to spin off Altucell also, and that is why they are getting a third party appraisal right not.

Quote:

---

As we move forward with a third-party evaluation of ALTuCELL by a leading pharmaceutical appraisal consulting firm, we are building a roadmap for the future to realize the massive market opportunity for the ALTuCELL IP portfolio, and we sincerely hope that the market will recognize the huge value that we are building in the NuGenerex Family of companies.”

---